机译:P239S palladin变体在遗传性或早期发作的胰腺癌中所占比例不大
Sam Minuk Cancer Genetics and Biomarker Laboratories Samuel Lunenfeld Research Institute Toronto Canada;
Sam Minuk Cancer Genetics and Biomarker Laboratories Samuel Lunenfeld Research Institute Toronto Canada;
Familial Gastrointestinal Cancer Registry Mount Sinai Hospital Toronto Canada;
Sam Minuk Cancer Genetics and Biomarker Laboratories Samuel Lunenfeld Research Institute Toronto Canada;
Women’s College Research Institute University of Toronto Toronto Canada;
Department of Medical Oncology and Hematology and Division of Experimental Therapeutics Ontario Cancer Institute/Princess Margaret Hospital University of Toronto Toronto Canada;
Women’s College Research Institute University of Toronto Toronto Canada;
Sam Minuk Cancer Genetics and Biomarker Laboratories Samuel Lunenfeld Research Institute Toronto Canada;
机译:P239S palladin变体在遗传性或早期发作的胰腺癌中所占比例不大。
机译:P239S palladin变体在遗传性或早期发作的胰腺癌中所占比例不大
机译:遗传性乳腺癌和卵巢癌的德国联盟的标准,用于遗传乳腺癌和卵巢癌风险基因的种系序列变异
机译:遗传性非息肉病结直肠癌,家族性腺瘤性息肉,炎性肠病和散发性结直肠癌的内窥镜指南
机译:在遗传癌基因中具有不确定意义的个体的医学决策,以及Chek2致病变异的人
机译:遗传性乳腺癌和卵巢癌家族的早期乳腺癌患者的GT198(PSMC3IP)种系变异
机译:P239S Palladin变体不会占遗传或早期发病胰腺癌的显着分数